News

  • 18 March 2019

    Sutro doses first patient in Phase I trial of STRO-002

    Sutro Biopharma has dosed the first patient in a Phase I clinical trial of anti-folate receptor alpha (FoIRα) antibody-drug conjugate (ADC) STRO-002 to treat patients with ovarian and endometrial cancers.

  • 18 March 2019

    Bristol-Myers and Pfizer report positive AUGUSTUS trial data

    The Bristol-Myers Squibb-Pfizer Alliance has reported positive results from the Phase IV AUGUSTUS trial that evaluated Eliquis (apixaban) versus vitamin K antagonists (VKAs) to treat patients with non-valvular atrial fibrillation...

  • 15 March 2019

    Xeris initiates treatment in Phase II liquid glucagon trial

    Xeris Pharmaceuticals has commenced dosing in a Phase II clinical trial being conducted to assess its ready-to-use liquid glucagon in type 1 diabetes patients experiencing episodes of exercise-induced hypoglycaemia (EIH).

Go Top